These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 28213199)

  • 1. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
    Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
    Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of all-cause mortality in abdominal obesity phenotypes: Tehran Lipid and Glucose Study.
    Doustmohamadian S; Serahati S; Barzin M; Keihani S; Azizi F; Hosseinpanah F
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):241-248. PubMed ID: 28139376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically healthy obesity and the risk for subclinical atherosclerosis.
    Kim TJ; Shin HY; Chang Y; Kang M; Jee J; Choi YH; Ahn HS; Ahn SH; Son HJ; Ryu S
    Atherosclerosis; 2017 Jul; 262():191-197. PubMed ID: 28385392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of incident obesity phenotype in nonobese healthy adults.
    Eftekharzadeh A; Asghari G; Serahati S; Hosseinpanah F; Azizi A; Barzin M; Mirmiran P; Azizi F
    Eur J Clin Invest; 2017 May; 47(5):357-365. PubMed ID: 28294315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
    PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population.
    Dhana K; Koolhaas CM; van Rossum EF; Ikram MA; Hofman A; Kavousi M; Franco OH
    PLoS One; 2016; 11(4):e0154273. PubMed ID: 27100779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between obesity phenotypes in adolescents and adult metabolic syndrome: Tehran Lipid and Glucose Study.
    Asghari G; Hosseinpanah F; Serahati S; Haghi S; Azizi F
    Br J Nutr; 2019 Dec; 122(11):1255-1261. PubMed ID: 31506131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.
    Oh CM; Park JH; Chung HS; Yu JM; Chung W; Kang JG; Moon S
    Medicine (Baltimore); 2020 Sep; 99(38):e22036. PubMed ID: 32957321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Metabolic Phenotypes of Body Fatness and Incident Stroke: A Prospective Cohort Study of Chinese Community Residents.
    Tang M; Zhao Q; Yi K; Wu Y; Xiang Y; Zaid M; Cui S; Su X; Yu Y; Zhao G; Jiang Y
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Metabolic Phenotypes of Obesity and Risk of Coronary Artery Calcium Progression and Incident Cardiovascular Disease Events: The CARDIA Study.
    Gao JW; You S; Liu ZY; Hao QY; Wang JF; Vuitton DA; Zhang SL; Liu PM
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):677-688. PubMed ID: 35387482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study.
    Wei D; González-Marrachelli V; Melgarejo JD; Liao CT; Hu A; Janssens S; Verhamme P; Van Aelst L; Vanassche T; Redon J; Tellez-Plaza M; Martin-Escudero JC; Monleon D; Zhang ZY
    Cardiovasc Diabetol; 2023 Apr; 22(1):82. PubMed ID: 37029406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Concurrent Changes in Metabolic Health and Weight on Cardiovascular Disease Risk: A Nationally Representative Cohort Study.
    Bae YS; Choi S; Lee K; Son JS; Lee H; Cho MH; Koo HY; Cho IY; Chang J; Kim K; Kim SM; Park SM
    J Am Heart Assoc; 2019 Sep; 8(17):e011825. PubMed ID: 31451053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis.
    Eckel N; Meidtner K; Kalle-Uhlmann T; Stefan N; Schulze MB
    Eur J Prev Cardiol; 2016 Jun; 23(9):956-66. PubMed ID: 26701871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of chronic kidney disease in a metabolically healthy obese population.
    Jung CH; Lee MJ; Kang YM; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Kidney Int; 2015 Oct; 88(4):843-50. PubMed ID: 26108064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.